The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hospital readmission rate for febrile neutropenia (FN) following high dose cytarabine (HiDAC) consolidation chemotherapy for acute myeloid leukemia (AML).
 
Caitlin Siebenaller
No Relationships to Disclose
 
Tomas Radivoyevitch
No Relationships to Disclose
 
Connie Cheng
No Relationships to Disclose
 
Hetty Carraway
Consulting or Advisory Role - Amgen; Celgene; Incyte
Speakers' Bureau - Baxalta; Celgene
Research Funding - Celgene
 
Sudipto Mukherjee
No Relationships to Disclose
 
Anjali S. Advani
No Relationships to Disclose
 
Aaron Thomas Gerds
Consulting or Advisory Role - AstraZeneca/MedImmune; CTI; Incyte
Research Funding - Celgene; CTI; Gilead Sciences; Incyte; Pfizer; Roche/Genentech
 
Aziz Nazha
No Relationships to Disclose
 
Jaroslaw P. Maciejewski
No Relationships to Disclose
 
Marc A. Earl
No Relationships to Disclose
 
Madeline Waldron
No Relationships to Disclose
 
Mikkael A. Sekeres
Consulting or Advisory Role - Celgene; Millennium